Envista Holdings Corp (NVST) - Stock Analysis
Last updated: Apr 26, 2026
Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
Envista presents strong Q4 2025 beats, positive analyst upgrades, a raised full-year guidance, robust institutional buying, and a ~24% price gain with breakout above 21-day SMA, supported by product momentum in implants and imaging, though tariff and macro risks temper short-term certainty.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Fundamental Analysis
Key Financial Insights: ⢠Liquidity Strength ⢠Thin Margins ⢠Cash Flow Support NVST has solid liquidity and strong free cash flow, but thin profit margins, high valuation, and intangible-heavy equity make the stock a cautious hold rather than an obvious buy.
Price Behavior
Key Price Behavior Insights: ⢠Recovering base ⢠Near-term resistance ⢠Softening momentum Support Level: $25.8â$26.0 Resistance Level: $27.8â$28.0 NVST shows a modest short-term uptrend and recovering base, but it must hold $25.8â$26.0 and break above $27.8â$28.0 to confirm further upside.
Sentiment & News
Key News Insights: ⢠Share-price strength ⢠Value-stock appeal ⢠Earnings catalyst NVST's recent headlines point to strong momentum, favorable long-term fundamentals, and a positive setup ahead of its upcoming Q1 2026 earnings report.
AI Summary
NVST is no longer just a cheap turnaround: recent broad-based growth, margin expansion, and higher guidance suggest real operational improvement, but the stock still deserves a discount until management proves earnings can hold up through China disruption, tariffs, and thin net margins.
Description
Envista Holdings Corp., headquartered in Brea, California, manufactures and sells a broad range of dental products and tools and employs about 12,800 full-time staff. The company operates two reporting segments: Specialty Products & Technologies, which supplies dental implant and prosthetic systems, orthodontic products and related treatment software; and Equipment & Consumables, which provides dental office equipment, imaging and visualization systems, restorative and endodontic materials, and infection-prevention supplies. Its offerings support diagnosis, treatment and routine clinical procedures across general and specialty dental practices.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Feb 10 | Feb 17 | NVST | Envista Holdings Corp | Envista presents strong Q4 2025 beats, positive analyst upgrades, a raised full-year guidance, robust institutional buying, and a ~24% price gain with breakout above 21-day SMA, supported by product momentum in implants and imaging, though tariff and macro risks temper short-term certainty. | Closed | -7.0% |